newsfilter
← Latest News
PR Newswire·

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

Servier, an independent international pharmaceutical group governed by a foundation, and Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) ("Day One"), ...